The qualified presumption of safety assessment and its role in EFSA risk evaluations: 15 years past.


Journal

FEMS microbiology letters
ISSN: 1574-6968
Titre abrégé: FEMS Microbiol Lett
Pays: England
ID NLM: 7705721

Informations de publication

Date de publication:
01 01 2019
Historique:
received: 10 08 2018
accepted: 07 12 2018
pubmed: 12 12 2018
medline: 26 9 2019
entrez: 12 12 2018
Statut: ppublish

Résumé

Microorganisms are intentionally added at different stages of the food and feed chain (food or feed additive, novel food or plant protection product) and are subjected to regulation and safety assessment by the European Food Safety Authority. Safety evaluation is based on application dossiers for market authorisation to the European Commission. The qualified presumption of safety (QPS) concept was developed in 20031 to provide a harmonised generic safety pre-appraisal of the above microorganisms. Unambiguously defined biological taxonomic units (TUs) are assessed for their body of knowledge, their safety and their end use. Identified safety concerns for a certain TU can be, where reasonable in number and not universally present, reflected as 'qualifications.' Strains belonging to TUs having QPS status may benefit of a fast track evaluation. The lowest TU for which the QPS status is granted is the species level for bacteria and yeasts and the family for viruses. The QPS concept is also applicable to genetically modified microorganisms used for production purposes. Based on the current body of knowledge and/or the ambiguous taxonomic position, some TUs, such as filamentous fungi, bacteriophages, Enterococcus faecium, Escherichia coli, Streptomyces spp. and Oomycetes, are not considered liable for QPS status.

Identifiants

pubmed: 30535073
pii: 5237703
doi: 10.1093/femsle/fny260
pmc: PMC6311724
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

EFSA J. 2017 Mar 14;15(3):e04664
pubmed: 32625421
Int J Syst Evol Microbiol. 2015 Nov;65(11):3763-3767
pubmed: 28056215
EFSA J. 2018 Jul 17;16(7):e05315
pubmed: 32625958
EFSA J. 2018 Mar 28;16(3):e05206
pubmed: 32625840
Food Chem Toxicol. 2007 Dec;45(12):2513-25
pubmed: 17692450
Regul Toxicol Pharmacol. 2015 Oct;73(1):164-71
pubmed: 26165564
EFSA J. 2018 Jan 24;16(1):e05131
pubmed: 32625678

Auteurs

Lieve Herman (L)

European Food Safety Authority (EFSA) Panel on Biological Hazards (BIOHAZ).
BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).

Marianne Chemaly (M)

European Food Safety Authority (EFSA) Panel on Biological Hazards (BIOHAZ).
BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
French Agency for Food, Environmental and Occupational Health Safety (Anses), Laboratory of Ploufragan-Plouzané, Unit of Hygiene and Quality of Poultry and Pork Products (UHQPAP), BP 53, 22440 Ploufragan, France.

Pier Sandro Cocconcelli (PS)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
DiSTAS, Università Cattolica del Sacro Cuore, Piacenza, Via Emilia Parmense 84, 29121 Piacenza, Italy.

Pablo Fernandez (P)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
Polytechnic University of Cartagena, Department of Food Engineering and E.A., Paseo Alfonso XIII 48, 30203 Cartagena, Spain.

Günter Klein (G)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).

Luisa Peixe (L)

European Food Safety Authority (EFSA) Panel on Biological Hazards (BIOHAZ).
BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
UCIBIO/REQUIMTE, Laboratório de Microbiologia, Faculdade de Farmácia, Universidade do Poro, Rua Jorge Viterbo Ferreira n° 228. 4050-313 Porto. Portugal.

Miguel Prieto (M)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
Institute of Food Science and Technology, Campus de Vegazana, s/n, University of León, 24007 León, Spain.

Amparo Querol (A)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
Food Biotechnology Department, Systems Biology in Yeast of Biotechnological Interest, Instituto de Agroquímica y Tecnología de los Alimentos, IATA-CSIC, C/ Catedrático Agustín Escardino Benlloch, 7, E-46980 Paterna - Valencia - Spain.

Juan Evaristo Suarez (JE)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
Área de Microbiología, Facultad de Medicina, Universidad de Oviedo, Julián Clavería 6, 33006 Oviedo, Spain.

Ingvar Sundh (I)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
Swedish University of Agricultural Sciences (SLU), Department of Molecular Sciences, PO Box 7015, SE-75007 Uppsala, Sweden.

Just Vlak (J)

BIOCONTAM BIOHAZ WG on the update of the list of QPS recommended biological agents intentionally added to food or feed as notified to EFSA (2017-19) (M-2016-0211).
Laboratory of Virology, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PD Wageningen, The Netherlands.

Sandra Correia (S)

Unit of Biological Hazards and Contaminants (BIOCONTAM), European Food Safety Authority (EFSA), via Carlo Magno 1A, 43126 Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH